0001558370-23-001085 Sample Contracts

SECURITIES PURCHASE AGREEMENT

Securities Purchase Agreement • February 9th, 2023 • Fortress Biotech, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Securities Purchase Agreement
• Filed
  February 9th, 2023
• Company
  Fortress Biotech, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This Securities Purchase Agreement (this “Agreement”) is dated as of February 7, 2023, between Fortress Biotech, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

Re: Common Stock Purchase Warrants in Designated Subsidiaries

Common Stock Purchase Warrants • February 9th, 2023 • Fortress Biotech, Inc. • Pharmaceutical preparations

• Contract Type
  Common Stock Purchase Warrants
• Filed
  February 9th, 2023
• Company
  Fortress Biotech, Inc.
• Industry
  Pharmaceutical preparations

This letter agreement (the “Letter Agreement”) is by and between Fortress Biotech, Inc. (the “Company”), and the investors identified on the signature pages hereto (the “Investors”) and collectively the (“Parties”). Reference is made to that certain Securities Purchase Agreement, dated February 7, 2023 (the “Securities Purchase Agreement”), in which the Investors are purchasing from the Company shares of the Company’s Common Stock, $0.001 par value (the “Common Stock”). Concurrently with the purchase of the Common Stock, the parties have agreed that the Investors will receive rights to acquire warrants to purchase certain common stock in the Designated Subsidiaries (as defined below), to the extent and as limited by the below agreements.